Eurofins, FR0014000MR3

Eurofins stock heads into the open after a flat Paris close

Published on 09/11/2026 at 03:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
At the close on September 9, 2026, Eurofins stock finished nearly unchanged on Euronext Paris, with a tight intraday range while the CAC 40 fell 1.9 percent. A disclosure of voting rights and share capital released on September 10, 2026 frames today’s session for Eurofins stock.
Eurofins, FR0014000MR3, Illustration mit AI erstellt.

Eurofins stock closed on Euronext Paris at a level described as little changed on September 9, 2026, with the price sitting comfortably within its intraday high and low and the daily move close to 0 percent in euros per exchange data. The session saw a tight trading range and routine volume, while the CAC 40 benchmark index closed at 8,156.67 points, down 1.94% on September 9, 2026, highlighting that Eurofins stock held up better than the broader French market in that session.

September 9, 2026 in numbers

Eurofins Scientific SE (ISIN FR0014000MR3, Euronext Paris: ERF) was reported to have finished trading on Euronext Paris on September 9, 2026 at a closing price that remained well within the day’s high and low, with trading volume characterized as routine for the stock per a recent market wrap. As Ad-hoc-news summarized on September 10, 2026, Eurofins stock ended the September 9, 2026 session on Euronext Paris little changed, with a muted intraday pattern against a sharply lower CAC 40 index. On the same day, the CAC 40 closed at 8,156.67 points, down 1.94%, according to data from Euronext Paris reported by Zonebourse, underscoring that Eurofins stock’s nearly flat performance outpaced the broad French equity benchmark in that session.

Capital structure disclosure shapes today

Looking ahead to today’s session on September 11, 2026, Eurofins is in focus after a capital structure release on September 10, 2026. As Yahoo Finance reported from a Business Wire announcement dated September 10, 2026, Eurofins Scientific SE disclosed its total number of shares and voting rights as of August 31, 2026, stating that the share capital comprised 176,000,000 shares and that the total number of voting rights attached to those shares, including suspended voting rights, stood at 362,395,012. The same disclosure was also published as regulated news on the Euronext company news feed on September 10, 2026, according to Euronext, providing investors with updated transparency on Eurofins’ capital and voting rights ahead of today’s trading on Euronext Paris.

Disclaimer...
en | FR0014000MR3 | EUROFINS | boerse | 70084604 |